Insider · CIK 0001316851

Nark Ted C

Reports to the SEC for 4 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001316851

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	325,848
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2025-11-17	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$11.72	−$586K	291,029
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	341,029
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	300,771
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	224,318
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	144,190
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2021-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−46.2K sh	—	—	0
2021-05-06	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+46.2K sh	—	—	108,784
2021-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+35.4K sh	—	—	35,406
2020-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,459 sh	—	—	62,566
2020-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,459 sh	—	—	0
2020-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+46.2K sh	—	—	46,218
2019-08-28	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+50K sh	$2.39	+$120K	56,107
2019-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,107 sh	—	—	0
2019-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,107 sh	—	—	6,107
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+6,459 sh	—	—	6,459
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+28K sh	—	—	28,044
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+25K sh	—	—	24,977
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+6,107 sh	—	—	6,107
2009-03-31	Real Goods Solar, Inc.A Award	Director	AAward	+3,234 sh	—	—	5,505
2008-12-31	Real Goods Solar, Inc.A Award	Director	AAward	+411 sh	—	—	2,271
2008-06-30	GAIAGAIA, INCA Award	Director	AAward	0 sh	—	—	2,248
2008-06-03	GAIAGAIA, INC · Option (right to buy)A Award	Director	AAward	0 sh	—	—	0
2007-06-30	GAIAGAIA, INCA Award	Director	AAward	+192 sh	—	—	1,787
2007-03-31	GAIAGAIA, INCA Award	Director	AAward	+492 sh	—	—	1,595
2006-06-22	GAIAGAIA, INCA Award	Director	AAward	+236 sh	—	—	483
2005-02-14	FTD Group, Inc.P Purchase	Director	PPurchase	+24.8K sh	$13.00	+$322K	156,446
2005-02-08	FTD Group, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
May 84
Nark Ted C0001628280-26-032910
SEC(opens sec.gov)
Nov 194
Nark Ted C0001628280-25-053188
SEC(opens sec.gov)
May 84
Nark Ted C0001628280-25-023993
SEC(opens sec.gov)
May 144
Nark Ted C0001628280-24-023246
SEC(opens sec.gov)
May 64
Nark Ted C0001628280-24-020740
SEC(opens sec.gov)
May 114
Nark Ted C0001209191-23-028731
SEC(opens sec.gov)
May 104
Nark Ted C0001209191-22-028159
SEC(opens sec.gov)
May 74
Nark Ted C0001209191-21-030812
SEC(opens sec.gov)
May 74
Nark Ted C0000899243-20-012261
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807